These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18453863)

  • 1. Methodological issues of non-inferiority trials in HIV-infected patients: a need for consensus?
    Richert L; Bouteloup V; Thiébaut R; Chêne G
    AIDS; 2008 May; 22(8):996-7. PubMed ID: 18453863
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ambiguity in a publication: is it a clinical trial or not?].
    Cuena Boy R
    An Med Interna; 2000 Mar; 17(3):160-1. PubMed ID: 10804645
    [No Abstract]   [Full Text] [Related]  

  • 3. Interleukin-2 in clinical trials: other factors to be considered.
    Nannini EC
    J Infect Dis; 2001 Feb; 183(4):679-80. PubMed ID: 11170999
    [No Abstract]   [Full Text] [Related]  

  • 4. Key clinical trials of non-nucleoside reverse transcriptase inhibitors in the treatment of chronic HIV-1 infection in adults.
    Williams I
    J HIV Ther; 2008 Mar; 13(1):19-23. PubMed ID: 18953269
    [No Abstract]   [Full Text] [Related]  

  • 5. Uncertainty as to whether the use of antiretroviral therapy for persons recently infected with HIV has a favorable risk-to-benefit ratio.
    Lundgren JD; Phillips AN; Neaton J
    Clin Infect Dis; 2009 Apr; 48(8):1162; author reply 1162-3. PubMed ID: 19292638
    [No Abstract]   [Full Text] [Related]  

  • 6. The current role of ritonavir-boosted protease inhibitors in the management of HIV infection.
    Wilkins E
    J HIV Ther; 2008 Mar; 13(1):9-18. PubMed ID: 18953268
    [No Abstract]   [Full Text] [Related]  

  • 7. The cost of access to HIV treatment.
    Galatowitsch P; Siegfried N
    Science; 2006 Dec; 314(5805):1540-1; author reply 1540-1. PubMed ID: 17158305
    [No Abstract]   [Full Text] [Related]  

  • 8. Adherence to HIV Regimens: A tailored nursing intervention fails to motivate one clinic's patients.
    Am J Nurs; 2006 Sep; 106(9):21. PubMed ID: 16954754
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary: resistance testing--a clinical perspective.
    Gazzard BG; Moyle G
    Sex Transm Infect; 1999 Jun; 75(3):141-2. PubMed ID: 10448386
    [No Abstract]   [Full Text] [Related]  

  • 10. 11th European AIDS Conference, Madrid, Spain, 24-27 October 2007.
    Rusconi S
    J HIV Ther; 2007 Dec; 12(4):102-4. PubMed ID: 18578094
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: "use of a Bayesian approach to decide when to stop a therapeutic trial: the case of a chemoprophylaxis trial in human immunodeficiency virus infection".
    van Noord PA; van der Tweel I
    Am J Epidemiol; 2005 Nov; 162(10):1033-5. PubMed ID: 16221807
    [No Abstract]   [Full Text] [Related]  

  • 12. IL-2 study web site available.
    AIDS Patient Care STDS; 2001 Apr; 15(4):230. PubMed ID: 11370652
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjusting for covariates in non-inferiority studies with margins defined as risk differences.
    Mohamed K; Embleton A; Cuffe RL
    Pharm Stat; 2011; 10(5):461-6. PubMed ID: 21956950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methodological and statistical aspects of equivalence and non inferiority trials].
    Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P
    Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women and non-whites new to HAART respond similarly to men and whites.
    AIDS Patient Care STDS; 2008 Sep; 22(9):762. PubMed ID: 18802978
    [No Abstract]   [Full Text] [Related]  

  • 16. 96-week CASTLE data show similar efficacy results.
    AIDS Patient Care STDS; 2008 Nov; 22(11):918. PubMed ID: 19043840
    [No Abstract]   [Full Text] [Related]  

  • 17. Comments on 'maintaining confidentiality of interim data to enhance trial integrity and credibility' by TR Fleming et al.
    Korn EL; Hunsberger S; Freidlin B; Smith MA; Abrams JS
    Clin Trials; 2008; 5(4):364-5; author reply 365-6. PubMed ID: 18697851
    [No Abstract]   [Full Text] [Related]  

  • 18. On non-inferiority margin and statistical tests in active control trials.
    Chow SC; Shao J
    Stat Med; 2006 Apr; 25(7):1101-13. PubMed ID: 16345042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Counterfactual links to the proportion of treatment effect explained by a surrogate marker.
    Taylor JM; Wang Y; Thiébaut R
    Biometrics; 2005 Dec; 61(4):1102-11. PubMed ID: 16401284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early antiretroviral therapy: the role of cohorts.
    Sabin CA
    Curr Opin HIV AIDS; 2009 May; 4(3):200-5. PubMed ID: 19532051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.